238 related articles for article (PubMed ID: 17545518)
1. Cross-linking of signal transducer and activator of transcription 3--a molecular marker for the photodynamic reaction in cells and tumors.
Henderson BW; Daroqui C; Tracy E; Vaughan LA; Loewen GM; Cooper MT; Baumann H
Clin Cancer Res; 2007 Jun; 13(11):3156-63. PubMed ID: 17545518
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy causes cross-linking of signal transducer and activator of transcription proteins and attenuation of interleukin-6 cytokine responsiveness in epithelial cells.
Liu W; Oseroff AR; Baumann H
Cancer Res; 2004 Sep; 64(18):6579-87. PubMed ID: 15374971
[TBL] [Abstract][Full Text] [Related]
3. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.
Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC
Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of photodynamic therapy using PAD-S31 and diode laser on human liver cancer cells.
Date M; Fukuchi K; Namiki Y; Okumura A; Morita S; Takahashi H; Ohura K
Liver Int; 2004 Apr; 24(2):142-8. PubMed ID: 15078479
[TBL] [Abstract][Full Text] [Related]
5. [Role of calcium signal in apoptosis and protective mechanism of colon cancer cell line SW480 in response to 5-aminolevulinic acid-photodynamic therapy].
Zheng JH; Shi D; Zhao Y; Chen ZL
Ai Zheng; 2006 Jun; 25(6):683-8. PubMed ID: 16764761
[TBL] [Abstract][Full Text] [Related]
6. Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes.
Maugain E; Sasnouski S; Zorin V; Merlin JL; Guillemin F; Bezdetnaya L
Oncol Rep; 2004 Sep; 12(3):639-45. PubMed ID: 15289849
[TBL] [Abstract][Full Text] [Related]
7. Study of the photodynamic effect on the A549 cell line by atomic force microscopy and the influence of green tea extract on the production of reactive oxygen species.
Tomankova K; Kolarova H; Bajgar R; Jirova D; Kejlova K; Mosinger J
Ann N Y Acad Sci; 2009 Aug; 1171():549-58. PubMed ID: 19723103
[TBL] [Abstract][Full Text] [Related]
8. Effect of photosensitizer dose on fluence rate responses to photodynamic therapy.
Wang HW; Rickter E; Yuan M; Wileyto EP; Glatstein E; Yodh A; Busch TM
Photochem Photobiol; 2007; 83(5):1040-8. PubMed ID: 17880498
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy for human oral squamous cell carcinoma and xenografts using a new photosensitizer, PAD-S31.
Date M; Sakata I; Fukuchi K; Ohura K; Azuma Y; Shinohara M; Matsuzaki K; Namiki Y; Takahashi H
Lasers Surg Med; 2003; 33(1):57-63. PubMed ID: 12866122
[TBL] [Abstract][Full Text] [Related]
10. Fluence rate as a modulator of PDT mechanisms.
Henderson BW; Busch TM; Snyder JW
Lasers Surg Med; 2006 Jun; 38(5):489-93. PubMed ID: 16615136
[TBL] [Abstract][Full Text] [Related]
11. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
[TBL] [Abstract][Full Text] [Related]
12. Comparison of sensitizers by detecting reactive oxygen species after photodynamic reaction in vitro.
Kolarova H; Bajgar R; Tomankova K; Nevrelova P; Mosinger J
Toxicol In Vitro; 2007 Oct; 21(7):1287-91. PubMed ID: 17561369
[TBL] [Abstract][Full Text] [Related]
13. Predictions of mathematical models of tissue oxygenation and generation of singlet oxygen during photodynamic therapy.
Yuan J; Mahama-Relue PA; Fournier RL; Hampton JA
Radiat Res; 1997 Oct; 148(4):386-94. PubMed ID: 9339955
[TBL] [Abstract][Full Text] [Related]
14. Hypericin-mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer.
Du HY; Olivo M; Tan BK; Bay BH
Int J Oncol; 2003 Nov; 23(5):1401-5. PubMed ID: 14532982
[TBL] [Abstract][Full Text] [Related]
15. Oxygen dependence of two-photon activation of zinc and copper phthalocyanine tetrasulfonate in Jurkat cells.
Mir Y; van Lier JE; Paquette B; Houde D
Photochem Photobiol; 2008; 84(5):1182-6. PubMed ID: 18331397
[TBL] [Abstract][Full Text] [Related]
16. Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells.
Dysart JS; Singh G; Patterson MS
Photochem Photobiol; 2005; 81(1):196-205. PubMed ID: 15469385
[TBL] [Abstract][Full Text] [Related]
17. Surfactant-polymer nanoparticles enhance the effectiveness of anticancer photodynamic therapy.
Khdair A; Gerard B; Handa H; Mao G; Shekhar MP; Panyam J
Mol Pharm; 2008; 5(5):795-807. PubMed ID: 18646775
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of singlet oxygen is useful for predicting the photodynamic effects in the treatment for experimental glioma.
Yamamoto J; Yamamoto S; Hirano T; Li S; Koide M; Kohno E; Okada M; Inenaga C; Tokuyama T; Yokota N; Terakawa S; Namba H
Clin Cancer Res; 2006 Dec; 12(23):7132-9. PubMed ID: 17145838
[TBL] [Abstract][Full Text] [Related]
19. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells.
Buytaert E; Matroule JY; Durinck S; Close P; Kocanova S; Vandenheede JR; de Witte PA; Piette J; Agostinis P
Oncogene; 2008 Mar; 27(13):1916-29. PubMed ID: 17952126
[TBL] [Abstract][Full Text] [Related]
20. Treatment-induced changes in tumor oxygenation predict photodynamic therapy outcome.
Wang HW; Putt ME; Emanuele MJ; Shin DB; Glatstein E; Yodh AG; Busch TM
Cancer Res; 2004 Oct; 64(20):7553-61. PubMed ID: 15492282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
